Identification of a Highly Antigenic Linear B Cell Epitope within Plasmodium vivax Apical Membrane Antigen 1 (AMA-1)

Apical membrane antigen 1 (AMA-1) is considered to be a major candidate antigen for a malaria vaccine. Previous immunoepidemiological studies of naturally acquired immunity to Plasmodium vivax AMA-1 (PvAMA-1) have shown a higher prevalence of specific antibodies to domain II (DII) of AMA-1. In the present study, we confirmed that specific antibody responses from naturally infected individuals were highly reactive to both full-length AMA-1 and DII. Also, we demonstrated a strong association between AMA-1 and DII IgG and IgG subclass responses. We analyzed the primary sequence of PvAMA-1 for B cell linear epitopes co-occurring with intrinsically unstructured/ disordered regions (IURs). The B cell epitope comprising the amino acid sequence 290-307 of PvAMA-1 (SASDQPTQYEEEMTDYQK), with the highest prediction scores, was identified in domain II and further selected for chemical synthesis and immunological testing. The antigenicity of the synthetic peptide was identified by serological analysis using sera from P. vivax-infected individuals who were knowingly reactive to the PvAMA-1 ectodomain only, domain II only, or reactive to both antigens. Although the synthetic peptide was recognized by all serum samples specific to domain II, serum with reactivity only to the full-length protein presented 58.3% positivity. Moreover, IgG reactivity against PvAMA-1 and domain II after depletion of specific synthetic peptide antibodies was reduced by 18% and 33% (P = 0.0001 for both), respectively. These results suggest that the linear epitope SASDQPTQYEEEMTDYQK is highly antigenic during natural human infections and is an important antigenic region of the domain II of PvAMA-1, suggesting its possible future use in pre-clinical studies.

Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and MSP-1(19) on the innate immune response

The recombinant apical membrane antigen 1 (AMA-1) and 19-kDa fragment of merozoite surface protein (MSP-1(19)) are the lead candidates for inclusion in a vaccine against blood stages of malaria due to encouraging protective studies in humans and animals. Despite the importance of an efficacious malaria vaccine, vaccine-related research has focused on identifying antigens that result in protective immunity rather than determining the nature of anti-malarial immune effector mechanisms. Moreover, emphasis has been placed on adaptive rather than innate immune responses. In this study, we investigated the effect of Plasmodium vivax vaccine candidates Pv-AMA-1 and Pv-MSP-1(19) on the immune response of malaria-naive donors. Maturation of dendritic cells is altered by Pv-AMA-1 but not Pv-MSP-1(19), as observed by differential expression of cell surface markers. In addition, Pv-AMA-1 induced an increased production of MIP-1 alpha/CCL3 and decreased production of TARC/CCL17 levels in both dendritic cells (DCs) and peripheral blood mononuclear cells (PBMCs). Finally, a significant pro-inflammatory response was elicited by Pv-AMA-1-stimulated PBMCs. These results suggest that the recombinant vaccine candidate Pv-AMA-1 may play a direct role on innate immune response and might be involved in parasite destruction. (C) 2007 Elsevier Ltd. All rights reserved.

Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells

The Apical Membrane Antigen-1 (AMA-1) is a well-characterized and functionally important merozoite protein and is currently considered a major candidate antigen for a malaria vaccine. Previously, we showed that AMA-1 has an influence on cellular immune responses of malaria-naive subjects, resulting in an alternative activation of monocyte-derived dendritic cells and induction of a pro-inflammatory response by stimulated PBMCs. Although there is evidence, from human and animal malaria model systems that cell-mediated immunity may contribute to both protection and pathogenesis, the knowledge on cellular immune responses in vivax malaria and the factors that may regulate this immunity are poorly understood. In the current work, we describe the maturation of monocyte-derived dendritic cells of P. vivax naturally infected individuals and the effect of P. vivax vaccine candidate Pv-AMA-1 on the immune responses of the same donors. We show that malaria-infected subjects present modulation of DC maturation, demonstrated by a significant decrease in expression of antigen-presenting molecules (CD1a, HLA-ABC and HLA-DR), accessory molecules (CD40, CD80 and CD86) and Fc gamma RI (CD64) receptor (P <= 0.05). Furthermore, Pv-AMA-1 elicits an upregulation of CD1a and HLA-DR molecules on the surface of monocyte-derived dendritic cells (P=0.0356 and P=0.0196, respectively), and it is presented by AMA-1-stimulated DCs. A significant pro-inflammatory response elicited by Pv-AMA-1-pulsed PBMCs is also demonstrated, as determined by significant production of TNF-alpha, IL-12p40 and IFN-gamma (P <= 0.05). Our results suggest that Pv-AMA-1 may partially revert DC down-modulation observed in infected subjects, and exert an important role in the initiation of pro-inflammatory immunity that might contribute substantially to protection. (c) 2009 Elsevier Ltd. All rights reserved.

Aspects of immunity for the AMA-1 family of molecules in humans and non-human primates malarias

The apical membrane antigen (AMA-1) family of malaria merozoite proteins is characterised by a high degree of inter-species conservation. Evidence that the protein (PK66/AMA-1) from the simian parasite Plasmodium knowlesi was protective in rhesus monkeys suggested that the 83kDa P. falciparum equivalent (PF83/AMA-1) should be investigated for protective effects in humans. Here we briefly review pertinent comparative data, and describe the use of an eukaryotic full length recombinant PF83/AMA-1 molecule to develop a sensitive ELISA for the determination of serological responses in endemic populations. The assay has revealed surprisingly high levels of humoral response to this quantitatively minor antigen. We also show that PK66/AMA-1 inhibitory mAb's are active against merozoites subsequent to release from schizont-infected red cells, further implicating AMA-1 molecules in red cell invasion.

Estereotipos publicitarios. El estereotipo del ama de casa en la actualidad en la publicidad de productos del sector de la limpieza en el hogar

En l'estudi que es presenta a continuació, s'analitza l'estereotip de mestressa de casa a la publicitat televisiva actual. Per a això, s’examinen les anteriors dècades amb la finalitat de seguir l'evolució d'aquest estereotip fins a l'actualitat, donant interès en els spots corresponents al sector neteja de la llar. Com a resultat de l'anàlisi, es podrà conèixer si hi ha hagut canvis, i quin tipus de canvis s'han produït.

Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children.

Background: This trial was conducted to evaluate the safety and immunogenicity of two virosome formulated malaria peptidomimetics derived from Plasmodium falciparum AMA-1 and CSP in malaria semi-immune adults and children.Methods: The design was a prospective randomized, double-blind, controlled, age-deescalating study with two immunizations. 10 adults and 40 children (aged 5-9 years) living in a malaria endemic area were immunized with PEV3B or virosomal influenza vaccine Inflexal (R) V on day 0 and 90.Results: No serious or severe adverse events (AEs) related to the vaccines were observed. The only local solicited AE reported was pain at injection site, which affected more children in the Inflexal (R) V group compared to the PEV3B group (p = 0.014). In the PEV3B group, IgG ELISA endpoint titers specific for the AMA-1 and CSP peptide antigens were significantly higher for most time points compared to the Inflexal (R) V control group. Across all time points after first immunization the average ratio of endpoint titers to baseline values in PEV3B subjects ranged from 4 to 15 in adults and from 4 to 66 in children. As an exploratory outcome, we found that the incidence rate of clinical malaria episodes in children vaccinees was half the rate of the control children between study days 30 and 365 (0.0035 episodes per day at risk for PEV3B vs. 0.0069 for Inflexal (R) V; RR = 0.50 [95%-CI: 0.29-0.88], p = 0.02).Conclusion: These findings provide a strong basis for the further development of multivalent virosomal malaria peptide vaccines.

Las estrategias de supervivencia económica que emplea la ama de casa en estado de pobreza, de la colonia Benito Juarez de Monterrey, Nuevo León

Tesis (Maestria en Trabajo Social) UANL

Participación política de la mujer en Coahuila : ama de casa, votante y ciudadana (in)completa.

Tesis (Maestría en Ciencias Sociales con Orientación en Desarrollo Sustentable) UANL, 2011.

Decreto Rectoral No.915 : Créase el progr ama de Especialización en Retina y Vítreo

Generación de nuevos programas académicos que resulten adecuados para la realidad del país y se constituyan en fuentes de soluciones y desarrollos innovadores para el avance y crecimiento de la nación colombiana. programa de Especialización en Retina y Vítreo.

Decreto Rectoral No. 894 : Créase el progr ama de Especialización en Gestión del Mejoramiento y la Productividad

Generación de nuevos programas académicos que resulten adecuados para la realidad del país y se constituyan en fuentes de soluciones y desarrollos innovadores para el avance y crecimiento de la nación colombiana, programa de Especialización en Gestión del Mejoramiento y la Productividad

Decreto rectoral No. 962 : Créase el progr ama de Maestría en Administración de Salud en convenio c on el CES de Medellín

Generación de nuevos programas académicos que resulten adecuados para la realidad del país y se constituyan en fuentes de soluciones y desarrollos innovadores para el avance y crecimiento de la nación colombiana programa de Maestría en Administración de Salud en convenio con el CES de Medellín.

Decreto rectoral No. 905 : Créase el progr ama de Especialización en Derecho y Tecnologías de Información

Generación de nuevos programas académicos que resulten adecuados para la realidad del país y se constituyan en fuentes de soluciones y desarrollos innovadores para el avance y crecimiento de la nación colombiana. Creación programa de Especialización en Derecho y Tecnologías de Información

Decreto rectoral No. 906 : Créase el progr ama de Especialización en Familia, Infancia, Juventud y Vejez

Generación de nuevos programas académicos que resulten adecuados para la realidad del país y se constituyan en fuentes de soluciones y desarrollos innovadores para el avance y crecimiento de la nación colombiana. Creación programa de Especialización en Familia, Infancia, Juventud y Vejez

Decreto rectoral No. 926 : Créase el progr ama de Especialización en Derecho Médico Sanitario

Generación de nuevos programas académicos que resulten adecuados para la realidad del país y se constituyan en fuentes de soluciones y desarrollos innovadores para el avance y crecimiento de la nación colombiana. Creación programa de Especialización en Derecho Médico Sanitario

Ama-hizkuntzak ez du gramatikaren barnerakuntzaren ordenamendua baldintzatzen.'La lengua materna no condiciona el ordenamiento de la interiorizaci??n de la gram??tica'

Resumen tomado de la publicaci??n